Peer review reports
From: Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium
Original Submission |
12 Feb 2012 |
Submitted |
Original manuscript
|
23 Feb 2012 |
Author responded |
Author comments - Maria Goossens
|
Resubmission - Version 2 |
23 Feb 2012 |
Submitted |
Manuscript version 2
|
Publishing |
21 Mar 2012 |
Editorially accepted |
|
21 Mar 2012 |
Article published |
10.1186/1471-2490-12-8
|
Learn about peer review